Vir Biotechnology, Inc.
Returns on Capital
| Fiscal Year | ROE | ROI | ROA |
|---|---|---|---|
| FY2021 | 36.9% | 36.9% | 27.0% |
| FY2022 | 24.8% | 24.8% | 18.4% |
| FY2023 | -38.7% | -38.7% | -32.1% |
| FY2024 | -45.4% | -45.4% | -37.3% |
| FY2025 | -57.2% | -57.2% | -43.7% |
Returns on Capital
| Fiscal Year | ROE | ROI | ROA |
|---|---|---|---|
| FY2021 | 36.9% | 36.9% | 27.0% |
| FY2022 | 24.8% | 24.8% | 18.4% |
| FY2023 | -38.7% | -38.7% | -32.1% |
| FY2024 | -45.4% | -45.4% | -37.3% |
| FY2025 | -57.2% | -57.2% | -43.7% |